SNF Platform Study of HR+/ HER2-advanced Breast Cancer

Conditions

• Breast Neoplasm
• Breast Cancer
• Hormone Receptor Positive Tumor
• HER2-negative Breast Cancer
• Advanced Breast Cancer

Interventions

• DRUG: PIK3CA inhibitor
• DRUG: AKT inhibitor
• DRUG: Carrelizumab
• DRUG: Famitinib
• DRUG: Fluzoparib
• DRUG: Dalpiciclib
• DRUG: SHR-A1811
• DRUG: Everolimus
• DRUG: Aromatase Inhibitors or Fulvestrant
• DRUG: Goserelin
• DRUG: TPC
• DRUG: Sorafenib
• DRUG: Apatinib
• DRUG: SHR-A1921
• DRUG: SHR-A2102
• DRUG: SHR-A2009
• DRUG: SHR-1167
• DRUG: SHR-6209
• DRUG: bevacizumab

Sponsor

Fudan University

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]
• [object Object]